Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06336369 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Brown Adipose Tissue Activity in Gilbert's Syndrome

StatusCompleted
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial completed Final enrollment: 48 participants (planned 80) · Primary completion date changed from estimate of Jan 15, 2027 to Sep 15, 2026 · Study completion date changed from estimate of Jan 15, 2027 to Oct 5, 2026 · 4 more Show 7 more changesShow less
    • Final enrollment: 48 participants (planned 80)
    • Primary completion date changed from estimate of Jan 15, 2027 to Sep 15, 2026
    • Study completion date changed from estimate of Jan 15, 2027 to Oct 5, 2026
    • Eligibility criteria shortened, about 22 words
    • Study description expanded, about 9 words
    • Site details revised
    • Publications: details revised at 18 of 18 entries
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this case-control study is to investigate energy metabolism and brown adipose tissue (BAT) activity in individuals with Gilbert's syndrome (GS) and controls. The main focus of the study is to analyze: 1. the link between bilirubin metabolism and metabolic health. 2. energy metabolism and body composition in individuals with Gilbert's syndrome and control subjects 3. brown adipose tissue activity in Gilbert's syndrome and healthy controls. Participants will undergo the following investigations: 1. cold exposure 2. PET-CT imaging with 18-F-FDG 3. MRI imaging of liver, abdominal fat and muscle 4. blood sampling 5. indirect calorimetry 6. bioelectrical impedance analysis 7. infrared thermography Researchers will compare individuals with GS and control subjects in terms of metabolic health, body composition and BAT activity.
Trial Details
NCT Number NCT06336369
Lead Sponsor Medical University of Vienna
Collaborators: University of Vienna, Griffith University
Conditions Gilbert Syndrome
Enrollment 48 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov